本文报告急,慢性型肝昏迷各1例,经输注FLC后24—48小时内苏醒,与文献报告资料一致。FLC治疗肝衰竭的确切机理尚不清楚,目前认为可能是输注肝细胞或肝细胞器提供了暂时而有效的肝脏代偿支持作用以及阻止受体肝细胞坏死及促进肝细胞再生作用。输注FLC可不考虑血型相符问题,除少数病人短暂发热外,未见不良反应。 This article reports acute and chronic hepatic coma in 1 case, 24-48 hours after infusion of FLC wake up, consistent with the literature reported. The exact mechanism of FLC in the treatment of liver failure is not yet clear, and it is currently considered that transfusion of hepatocytes or hepatic organelles may provide transient and effective hepatic compensatory support and prevent hepatic cell necrosis and hepatocyte regeneration. Infusion FLC can not consider the blood type consistent with the problem, in addition to a small number of patients with short-term fever, no adverse reactions.